lomerizine has been researched along with Cognitive Dysfunction in 1 studies
lomerizine: used to treat migraines
Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The patient was administered lomerizine (10 mg/day), but the patient's cognitive impairment and cerebral atrophy continued to worsen." | 7.88 | [CADASIL with cysteine-sparing NOTCH3 mutation manifesting as dissociated progression between cognitive impairment and brain image findings in 3 years: A case report]. ( Kuriyama, M; Mizuno, T; Mizuta, I; Shiga, Y; Shimoe, Y; Tachiyama, K, 2018) |
| " The patient was administered lomerizine (10 mg/day), but the patient's cognitive impairment and cerebral atrophy continued to worsen." | 3.88 | [CADASIL with cysteine-sparing NOTCH3 mutation manifesting as dissociated progression between cognitive impairment and brain image findings in 3 years: A case report]. ( Kuriyama, M; Mizuno, T; Mizuta, I; Shiga, Y; Shimoe, Y; Tachiyama, K, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tachiyama, K | 1 |
| Shiga, Y | 1 |
| Shimoe, Y | 1 |
| Mizuta, I | 1 |
| Mizuno, T | 1 |
| Kuriyama, M | 1 |
1 other study available for lomerizine and Cognitive Dysfunction
| Article | Year |
|---|---|
[CADASIL with cysteine-sparing NOTCH3 mutation manifesting as dissociated progression between cognitive impairment and brain image findings in 3 years: A case report].
Topics: Atrophy; Brain; CADASIL; Cerebrovascular Circulation; Cognition; Cognitive Dysfunction; Cysteine; Di | 2018 |